BlackRock, Inc. (BLK) 13D/13G Filings for Albireo Pharma, Inc. (ALBO)

BlackRock, Inc. 13D and 13G filings for Albireo Pharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-03-08
2:01 pm
Sale		 2023-02-28 13G Albireo Pharma, Inc.
ALBO		 BLACKROCK INC
BLK		 506,425
2.400%		 -838,472decrease
(-62.34%)		 Filing
2023-01-31
5:52 pm
Purchase		 2022-12-31 13G Albireo Pharma, Inc.
ALBO		 BLACKROCK INC
BLK		 1,344,897
6.500%		 176,114increase
(+15.07%)		 Filing
2022-02-02
7:11 pm
Sale		 2021-12-31 13G Albireo Pharma, Inc.
ALBO		 BLACKROCK INC
BLK		 1,168,783
6.100%		 -73,997decrease
(-5.95%)		 Filing
2021-02-02
3:13 pm
Purchase		 2020-12-31 13G Albireo Pharma, Inc.
ALBO		 BLACKROCK INC
BLK		 1,242,780
6.500%		 556,324increase
(+81.04%)		 Filing